-+ 0.00%
-+ 0.00%
-+ 0.00%

Psyence BioMed Plans to Advance Vertically Integrated Platform and Product and Clinical Development Program, Targeting Phase IIb Trial Execution and Regulatory Readiness

Reuters·03/11/2026 13:25:23

Please log in to view news